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A B S T R A C T   
Background: Research suggests that frailty is associated with higher inflammation levels. We investigated the 
longitudinal association between chronic inflammation and frailty progression. 
Methods: Participants of the Lothian Birth Cohort 1936, aged 70 at baseline were tested four times over 12 years 
(wave 1: n = 1091, wave 4: n = 550). Frailty was assessed by; the Frailty Index at waves 1–4 and Fried 
phenotype at waves 1, 3 and 4. Two blood-based inflammatory biomarkers were measured at wave 1: Fibrinogen 
and C-reactive protein (CRP). 
Results: Fully-adjusted, linear mixed effects models showed higher Fibrinogen was significantly associated with 
higher wave 1 Frailty Index score (β = 0.011, 95% CI[0.002,0.020], p  <  .05). Over 12 year follow-up, higher 
wave 1 CRP (β = 0.001, 95% CI[0.000,0.002], p  <  .05) and Fibrinogen (β = 0.004, 95% CI[0.001,0.007], 
p  <  .05) were significantly associated with increased Frailty Index change. For the Fried phenotype, wave 1 
Pre-frail and Frail participants had higher CRP and Fibrinogen than Non-frail participants (p  <  .001). Logistic 
regression models calculated risk of worsening frailty over follow-up and we observed no significant association 
of CRP or Fibrinogen in minimally-adjusted nor fully-adjusted models. 
Conclusions: Findings showed a longitudinal association of higher wave 1 CRP and Fibrinogen on worsening 
frailty in the Frailty Index, but not Fried Phenotype. A possible explanation for this disparity may lie in the 
conceptual differences between frailty measures (a biopsychosocial vs physical approach). Future research, 
which further explores different domains of frailty, as well the associations between improving frailty and in-
flammation levels, may elucidate the pathway through which inflammation influences frailty progression. This 
may improve earlier identification of those at high frailty risk.   
1. Introduction 
Although a definitive definition of frailty has yet to be established, it 
is generally accepted to refer to a clinical syndrome associated with an 
increased state of vulnerability in older adults (Iwasaki et al., 2018). 
This vulnerability increases an individual's risk of injury, disability, 
hospitalisation, and mortality (Fried et al., 2001). However, our un-
derstanding of frailty's aetiology remains poor (Hubbard and 
Woodhouse, 2010). Inflammation is a defence response undertaken by 
the immune system to combat harmful factors affecting the body 
(Pawelec et al., 2014). However, particularly in later life, chronic in-
flammation at low levels (inflamm-ageing) may develop even in the 
absence of infection (Samson et al., 2019). In order to measure in-
flammation, markers obtained from blood samples are often used. For 
instance, Fibrinogen, a plasma protein synthesised in the liver increases 
in the blood in response to systemic inflammation (Davalos and 
Akassoglou, 2012). Similarly, C-reactive protein (CRP), an acute phase 
protein found in blood plasma increases in concentration in response to 
inflammatory cytokines like Interleukin 6 (IL-6), and thus acts as a 
reliable indicator of inflammation in the body (Sproston and Ashworth, 
2018). Elevated levels of inflammatory markers like Fibrinogen and 
CRP are consistently found amongst older people (Singh and Newman, 
2011) and could potentially contribute to an increased risk of various 
diseases in later life (Pawelec et al., 2014; Sanada et al., 2018). Much 
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like frailty, inflamm-ageing is seen as a significant risk factor for mor-
bidity and mortality (Sanada et al., 2018) and is more pronounced in 
women (Samson et al., 2019). A recent systematic review and meta- 
analysis of 31 cross-sectional studies showed that frail and pre-frail 
individuals had significantly higher levels of inflammatory markers, 
including Fibrinogen and CRP (Soysal et al., 2016, 2017). These find-
ings make the interaction between frailty and inflammation of parti-
cular interest. 
A salient issue in frailty research is the surplus of measurement tools 
available. Frailty is measured differently both in conception and oper-
ationalisation. Two of the main measurement tools illustrate this dis-
parity: the Fried phenotype measures frailty according to five physical 
measurements (weight loss, exhaustion, level of physical activity, 
walking speed, and weakness) and categorises individuals as Non-frail, 
Pre-frail, or Frail (Fried et al., 2001); the Frailty Index (FI) measures 
frailty as a continuous variable according to at least 30 physical, psy-
chological, and social deficits across an individual's life (Mitnitski et al., 
2001; Rockwood and Mitnitski, 2007). As far as we are aware, only four 
publications have examined the longitudinal association between in-
flammation and frailty, three of which used the Fried phenotype 
(Reiner et al., 2009; Baylis et al., 2013; Gale et al., 2013), and one (Puts 
et al., 2005) which used a self-created but unvalidated measure based 
on nine physical and psychological frailty indicators. In a meta-analysis 
of the four studies, no overall association was observed between in-
flammatory markers and incidence of frailty over time (Soysal et al., 
2016, 2017). In a 2005 frailty and inflammation paper, the lack of 
longitudinal research exploring this association was discussed (Puts 
et al., 2005). Over a decade later a 2016 review paper highlighted that 
there remains a need for more of this research (Soysal et al., 2016, 
2017). 
Here we test the association between frailty and inflammation in the 
Lothian Birth Cohort 1936 (LBC1936). By exploring the association of 
inflammation and frailty over time, it may be possible to determine 
markers which are able to predict frailty risk. This could have important 
implications for public health intervention strategies for the care of 
elderly people. A recent systematic review (Welstead et al., 2020), 
concluded that, in lieu of a gold standard frailty measurement tool, it 
may be beneficial to utilise multiple measures. Subsequently, we used 
both the FI and the Fried phenotype to assess associations with in-
flammation and evaluate any potential differences in findings according 
to the measure used. To our knowledge, no previous longitudinal stu-
dies have explored frailty and inflammation in this manner. Our goal 
was to test the association between baseline inflammation levels and 
progression of frailty by end of follow-up, 12 years later. We hy-
pothesised that those with higher baseline inflammation levels would 
also have an increased level of baseline frailty in both frailty measures. 
Over the follow-up, we predicted that higher baseline inflammation 
would be associated with a steeper trajectory of FI change during 
follow-up and a higher risk of Fried phenotype transition from Non- 
Frail to Pre-Frail or Frail. 
2. Methods 
2.1. Study sample 
From 2004 to 2007, 1091 participants from the Lothian Birth 
Cohort 1936 (LBC1936) with a mean (SD) age of 69 (0.83) years, 49.8% 
female, were recruited and tested at baseline. Follow-up waves were 
conducted every three years spanning 12 years in total (wave 2 
n = 866, wave 3 n = 697, wave 4 n = 550). Sample attrition across 
follow-up left 550 participants at wave 4. Table 1 reports summary 
information at each wave. For more details on the cohort, see the 
LBC1936 profile papers (Deary et al., 2011; Taylor et al., 2018; Deary 
et al., 2007). LBC1936 was conducted according to the Declaration of 
Helsinki guidelines with ethical permission obtained from the Multi- 
Centre Research Ethics Committee for Scotland (MREC/01/0/56), 
Lothian Research Ethics Committee (LREC/2003/2/29), and Scotland A 
Research Ethics Committee (07/MRE00/58). Written consent was ob-
tained from all participants. 
2.2. Inflammation measures 
At baseline, blood samples were drawn, and of interest to this study, 
analysed for two commonly used biomarkers of inflammation: CRP 
(mg/l) and Fibrinogen (g/L) (Del Giudice and Gangestad, 2018). CRP 
assays were undertaken with a dry slide immune-rate method with an 
OrthoFusion 5.1 FS analyser. Consistent with previous research (Corley 
et al., 2015), CRP values over 10 mg/l were excluded from analysis due 
to the likelihood that they represent acute illness. CRP distributions 
were positively skewed, however none of the transformations tried 
improved this distribution, and for the sake of interpretability, mea-
sures were left untransformed. Furthermore, inspection of residuals did 
not identify departure from distributional assumptions. Fibrinogen 
samples were obtained with a Clauss assay (Luciano et al., 2009), and 
measures were normally distributed and no values were excluded. 
2.3. Frailty measures 
The FI was constructed at each wave according to pre-established 
guidelines (Searle et al., 2008). We included 30 deficits covering dif-
ferent body systems (psychological, cognitive, and physical). Whilst 
some cut-off values were clear (e.g. a disease is present or absent), 
others were not (e.g. grip strength), in these cases previously estab-
lished methods were used (Searle et al., 2008). Deficits and cut-off 
values are reported in Table A1. For each participant the number of 
present deficits was summed and divided by the total number of deficits 
(n = 30). Computed scores ranged from 0 to 1, with higher scores re-
presenting a higher degree of frailty. 
The Fried phenotype is based on five pre-specified dimensions: 
weight loss, exhaustion, physical health, walking speed, and grip 
strength. The presence of one or two of these dimensions indicated that 
an individual is Pre-frail, whilst three or more indicated Frailty. Fried 
phenotype was calculated at all waves other than wave 2 due to in-
sufficient data. Full details are reported in Appendix A. 
2.4. Covariates 
For FI and Fried phenotype analyses we included covariates: age, 
sex, smoking status (current/ex/never), alcohol intake (units per week), 
years of formal full-time education, occupational social class (profes-
sional/managerial/skilled, non-manual/skilled manual or semiskilled/ 
unskilled), and childhood IQ (measured with the Moray House Test in 
the LBC1936 at age 11) (Penrose, 1949). Childhood IQ was included as 
a covariate due to previous findings in the LBC1936 indicating that 
lower intelligence in childhood is associated with increased in-
flammation (Luciano et al., 2009) and an increased risk of frailty in 
older age (Gale et al., 2016). For details on how social class and 
Childhood IQ was derived, see Appendix B. Additionally, for Fried 
phenotype analyses we added covariates that were not included for FI 
analyses due to their inclusion in the composition of the measure. These 
included: self-reported history of various chronic diseases, depressive 
symptoms from the Hospital Anxiety and Depression scale (HADS) 
(Zigmond and Snaith, 1983) and Body Mass Index (BMI). As one of the 
HADS questions was included in the composition of the Fried Pheno-
type, this question was removed when deriving the depressive symp-
toms covariate. 
2.5. Missing data 
Over the four waves, there were a small number of instances where 
it was not possible to take certain measures for some participants. In 
these instances we used multiple imputation with the MICE package in 
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R version 3.5.3 (Buuren and Groothuis-Oudshoorn, 2010; R Core Team, 
2018). Five imputations were used to estimate missing data needed for 
the creation of our frailty measures, and a total of 49 missing values 
were replaced with substituted values. 
2.6. Statistical analyses 
Due to the differences in how frailty is quantified in the Fried 
phenotype (categorical) and the FI (continuous), we used different 
statistical techniques for each measure. Linear mixed effects models 
using the LME4 package in R (R Core Team, 2018) were used to esti-
mate change in FI scores from baseline to wave 4 and evaluate the 
association between baseline CRP and Fibrinogen and frailty trajec-
tories. Models describing linear and accelerating change were fitted and 
adjusted for covariates, and then the best fitting model was chosen 
according to BIC fit indices. Fig. 1 illustrating the progression of FI over 
time was created using the GGPlot2 function in R (R Core Team, 2018). 
Logistic regression was undertaken with the GLM function in R (R 
Core Team, 2018) to calculate the association between baseline CRP 
and Fibrinogen on the odds of frailty transition in the Fried phenotype 
between baseline and wave 4 (transition/no transition). Transitions 
were considered present if there was a worsening in frailty status i.e. 
from Non-Frail to Pre-Frail or Frail, or Pre-frail to Frail. Improvements 
in frailty status were also seen over the follow-up period with ap-
proximately 12% of participants showing an improvement in frailty 
status. Due to the focus of our study on frailty decline, these cases were 
not included in our analyses. Pearson's correlation coefficients were 
used to assess the inter-relationships between the inflammatory mar-
kers. An initial baseline model was calculated which controlled for age 
and sex, before computing a final model adjusting for other covariates. 
t-tests were used to describe sex group differences and assess baseline 
associations between inflammation and baseline frailty. Due to the use 
of two separate outcomes, there was no requirement for multiple testing 
corrections. 
3. Results 
At baseline, a moderate correlation was seen between the Fried 
phenotype and the FI (rho = 0.43). This relationship was consistent at 
waves 3 and 4, where both frailty measures were also available 
(rho = 0.51 & 0.48, respectively). Baseline CRP and Fibrinogen showed 
a low positive correlation (rho = 0.28). T-tests found significantly 
higher levels of baseline FI scores for those who withdrew from the 
study compared to those who completed all waves (completers mean 
[SD] = 0.15 [0.08], withdrawers mean [SD] = 0.18 [0.09]; t 
[1065] = 6.06, p  <  .001). A significant difference between Fried 
Phenotype category and completers vs withdrawers was also found (t 
[1080] = 4.43, p  <  .001). Findings showed that 11.3% of with-
drawers compared to 5.8% of completers were categorised as frail by 
the Fried Phenotype at baseline. In total 145 out of a total 550 com-
pleters (26%) showed a transition to a worse frailty status over the 
follow-up period. Additionally, levels of baseline inflammation were 
higher for those who withdrew (CRP: completers mean [SD] = 3.27 
[2.32], withdrawers mean [SD] = 3.69 [2.55]; t[901] = 2.60, 
p  <  .01, Fibrinogen: completers mean [SD] = 3.22 [0.59], with-
drawers mean [SD] = 3.34 [0.68], t[1006] = 3.21, p  <  .01). Over the 
four waves of data, both CRP and Fibrinogen showed a small decrease, 
as seen in Figs. A1 and A2. 
3.1. Frailty index (FI) 
At baseline, no significant sex difference in the FI was observed 
(male mean [SD] = 0.16 [0.08], female mean [SD] = 0.17 [0.09]; t 
[1088] = −1.35, p = .18). The comparison of fit indices between 
models describing the trajectory change in FI at a constant rate and 
models describing an accelerating rate of change showed that the best- 
fitting model was a model that considers FI change as constant and 
linear (CRP model BIC = −6826; Fibrinogen model BIC = −7646). 
Results of both CRP and Fibrinogen models indicated a significant as-
sociation of time and FI scores, that is, scores increased on average by 
0.030 (95% CI:[0.01, 0.05], p  <  .01,) with each wave. Fig. 1 shows 
this increase across waves. Random effects estimated the average var-
iance of FI at baseline (SD = 0.07) and rate of FI change (SD = 0.02). 
Table 1 
Summary characteristics of participants at each LBC1936 wave.       
Variables Wave 1 (Baseline) Wave 2 Wave 3 Wave 4  
Participants (n) 1091 866 697 550 
Age in years, mean (SD) 69.6 (0.8) 72.5 (0.7) 76.3 (0.7) 79.4 (0.6) 
Female, n (%) 543 (49.8%) 418 (48.3%) 337 (48.4%) 275 (50%) 
FI, mean (SD) 0.16 (0.1) 0.18 (0.1) 0.20 (0.1) 0.21 (0.1) 
Fried phenotype, n (%) 
Non-frail 
Pre-frail 
Frail  
478 (44%) 
520 (48%) 
93 (8%)  
Insufficient data to construct phenotype  269 (39%) 
326 (47%) 
102 (14%)  
222 (40%) 
259 (47%) 
69 (13%) 
CRP (mg/l), mean (SD) 3.5 (2.4) 3.3 (2.4) 2.5 (2.3) 2.4 (2.2) 
Fibrinogen (g/L), mean (SD) 3.3 (0.6) 3.3 (0.6) 3.0 (0.6) 3.1 (0.5) 
Note. CRP: C - reactive protein; FI: Frailty Index.  
Fig. 1. A plot of Frailty Index trajectories and estimated mean over the course 
of follow-up. 
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Older age and lower childhood IQ were both associated with an in-
creased baseline FI (p  <  .001). In the CRP model, baseline CRP did not 
have a significant association with baseline FI score but did show a 
significant association with the slope of FI change longitudinally 
(β = 0.001, 95% CI: [0.000, 0.002], p  <  .05). In the Fibrinogen 
model, baseline Fibrinogen was shown to have a significant association 
with baseline FI score (β =0.011, 95% CI: [0.002, 0.020], p  <  .05) as 
well as a significant association with the slope of FI change long-
itudinally (β =0.004, 95% CI: [0.001, 0.007], p  <  .05). Full results are 
reported in Table 2. 
3.2. Fried phenotype 
At baseline there was a significant difference between Fried phe-
notype category membership and CRP (p  <  .001) and Fibrinogen 
(p  <  .001). Non-Frail participants had lower CRP (mean [SD] = 3.16 
[2.26]) and Fibrinogen (mean [SD] = 3.17 [0.55]) than Pre-Frail 
participants (CRP mean [SD] = 3.68 [2.55], Fibrinogen mean 
[SD] = 3.32 [0.65]) or Frail participants (CRP mean [SD] = 4.07 
[2.58], Fibrinogen mean [SD] = 3.60 [0.82]). The distribution of men 
and women did not differ significantly by baseline Fried phenotype 
category. Further cross-sectional results showed significant differences 
between Fried Phenotype categories and several covariates. Those in 
the Frail category had lower childhood IQ (p  <  .001), less education 
Table 2 
Results from the linear mixed effects models assessing Frailty Index change in the LBC1936.          
CRP (mg/l) linear mixed effects model (BIC = −6826) Fibrinogen (g/L) linear mixed effects model (BIC = −7646) 
Fixed effects β 95% CI p-Value β 95% CI p-Value  
Rate of change  0.031 0.008, 0.052  0.006⁎⁎  0.029 0.008, 0.050  0.007⁎⁎ 
Inflammation  0.002 −0.000, 0.004  0.113  0.011 0.002, 0.020  0.016⁎ 
Age  0.000 0.000, 0.000  0.000⁎⁎⁎  0.000 0.000, 0.000  0.000⁎⁎⁎ 
Sex  0.012 −0.000, 0.025  0.055  0.013 0.001, 0.025  0.038⁎ 
Smoking  0.010 −0.002, 0.022  0.114  0.010 −0.001, 0.022  0.085 
Alcohol intake  0.000 −0.000, 0.001  0.800  −0.000 −0.000, 0.000  0.949 
Social class  −0.003 −0.009, 0.003  0.343  −0.005 −0.011, 0.001  0.117 
Childhood IQ  −0.001 −0.002, −0.001  0.000⁎⁎⁎  −0.001 −0.002, −0.000  0.000⁎⁎⁎ 
Years of education  −0.004 −0.011, 0.002  0.160  −0.005 −0.011, 0.000  0.096 
Inflammation over time  0.001 0.000, 0.002  0.021⁎  0.004 0.001, 0.007  0.014⁎ 
Age over time  −0.000 −0.000, 0.000  0.115  −0.000 −0.000, 0.000  0.410 
Sex over time  −0.003 −0.007, 0.001  0.193  −0.004 −0.008, 0.000  0.092 
Smoking over time  0.004 −0.000, 0.008  0.055  0.005 0.001, 0.009  0.009⁎⁎ 
Alcohol intake over time  −0.000 −0.000, 0.000  0.247  −0.000 −0.000, 0.000  0.385 
Social class over time  −0.001 −0.003, 0.001  0.311  −0.001 −0.001, 0.009  0.524 
Childhood IQ over time  −0.000 −0.000, 0.000  0.538  −0.000 −0.000, 0.000  0.500 
Years of education over time  0.001 −0.002, 0.003  0.583  0.000 −0.002, 0.002  0.702 
Note. CRP: C - reactive protein; FI: Frailty Index. 
Units: Inflammation: CRP or Fibrinogen respectively; Smoking: Current, Ex, Never; Alcohol intake: units per week; Social class: professional, managerial, skilled non- 
manual, skilled manual, and semiskilled/unskilled. 
⁎⁎⁎ P  <  .001. 
⁎⁎ P  <  .01. 
⁎ P  <  .05.  
Table 3 
Results from the fully-adjusted logistic regression models assessing risk of Fried phenotype transition in the LBC1936.       
Variables CRP (mg/l) logistic regression model (AIC = 548) Fibrinogen (g/L) logistic regression (AIC = 612) 
Odds ratios (95% CI) p-Value Odds ratios (95% CI) p-Value  
Inflammation marker 1.03 (0.93, 1.13) 0.55 0.84 (0.58, 1.20) 0.34 
Age 1.21 (0.93, 1.58) 0.16 1.15 (0.89, 1.48) 0.27 
Sex 1.01 (0.63, 1.63) 0.96 1.04 (0.66, 1.63) 0.86 
Smoking Status 1.19 (0.76, 1.86) 0.44 1.30 (0.86, 1.98) 0.21 
Alcohol intake 1.00 (0.98, 1.02) 0.88 1.00 (0.94, 1.02) 0.81 
Years of Education 1.07 (0.86, 1.34) 0.52 1.09 (0.88, 1.33) 0.43 
Social class 0.89 (0.64, 1.25) 0.51 0.91 (0.64, 1.24) 0.55 
Childhood IQ 1.00 (0.98, 1.02) 0.89 1.00 (0.99, 1.08) 0.86 
BMI 1.04 (0.98, 1.10) 0.15 1.03 (0.98, 1.08) 0.19 
History of diabetes (Yes/No) 0.72 (0.25, 1.86) 0.52 1.24 (0.53, 2.76) 0.60 
History of cardiovascular disease (Yes/No) 0.88 (0.50, 1.54) 0.67 0.78 (0.46, 1.31) 0.36 
History of high cholesterol (Yes/No) 1.14 (0.69, 1.85) 0.61 1.23 (0.78, 1.93) 0.36 
History of stroke (Yes/No) 0.93 (0.19, 3.51) 0.92 1.20 (0.38, 3.49) 0.74 
History of thyroid disease (Yes/No) 1.22 (0.57, 2.47) 0.59 0.96 (0.46, 1.89) 0.90 
History of cancer (Yes/No) 0.79 (0.35, 1.63) 0.54 0.90 (0.43, 1.77) 0.76 
History of Parkinson's disease (Yes/No) 0.00 (N/Aa) 0.98 0.00 (N/Aa) 0.98 
History of arthritis (Yes/No) 0.95 (0.61, 1.48) 0.83 0.96 (0.63, 1.45) 0.84 
Number of depressive symptoms (HADS) 0.99 (0.88, 1.10) 0.83 0.99 (0.89, 1.10) 0.90 
Note. BMI: Body Mass Index; CRP: C - reactive protein; FI: Frailty Index; HADS: Hospital and Anxiety Depression Scale. 
Units: Inflammation marker: CRP, Fibrinogen; Smoking: Current, Ex, Never; Alcohol intake: units per week; Social class: professional, managerial, skilled non-manual, 
skilled manual, and semiskilled/unskilled. 
a Unable to calculate 95% CI due to small sample of Parkinson's disease case.  
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(p  <  .001), higher BMI (p  <  .001), higher depressive symptoms 
(p  <  .001), and higher instances of various chronic diseases including 
diabetes (p  <  .001), cardiovascular disease (p  <  .001), high choles-
terol (p  <  .01), stroke (p  <  .01), Parkinson's disease (p  <  .05), and 
arthritis (p  <  .001). Frail individuals were also more likely to identify 
as a current smoker (p  <  .01) and more likely to belong to a lower 
occupational social class (p  <  .001). Full details of baseline Fried 
Phenotype differences are reported in Table A2. 
Longitudinally, sex did not emerge as associated with the rate of 
transition between Fried phenotype categories. Of the 550 participants 
who completed follow-up, 5.8% were classified as frail at baseline 
compared to 12.5% at wave 4. Logistic regression models were used 
independently for CRP and Fibrinogen. In the baseline models with age 
and sex as covariates, neither CRP nor Fibrinogen showed a significant 
association with frailty transitions. Results in the fully-adjusted models 
remained non-significant both inflammatory biomarkers. Furthermore, 
no covariates showed significant associations with frailty transition. 
Full details are reported in Table 3. 
4. Discussion 
4.1. Summary of findings and comparison with other literature 
In this study, we investigated the association between two baseline 
inflammatory markers CRP and Fibrinogen, and frailty, as measured by 
the FI and the Fried phenotype, over 12 years of follow-up. Our hy-
pothesis that higher levels of baseline inflammation would be asso-
ciated with higher baseline frailty scores was partially supported; 
Fibrinogen, but not CRP, was cross-sectionally associated with FI 
scores. Whilst for the Fried phenotype both inflammation markers were 
higher in Pre-Frail and Frail participants compared to Non-Frail, find-
ings which are consistent with previous cross-sectional research (Soysal 
et al., 2016, 2017). Our longitudinal findings showed no significant 
associations of inflammation factors and Fried phenotype transitions 
across the follow-up. These results support previous null findings re-
ported in a meta-analysis of four longitudinal studies (Puts et al., 2005;  
Reiner et al., 2009; Baylis et al., 2013; Gale et al., 2013). However, we 
did find significant associations between both CRP and Fibrinogen on 
the FI slope of change, indicating that higher levels of these markers at 
baseline increase the gradient of FI score over time. This supports our 
hypothesis that rate of FI change is influenced by inflammation at 
baseline. Differences in findings between risk factors and these two 
frailty measures have been observed previously (Gale et al., 2018) and 
our findings that FI and Fried phenotype are only moderately correlated 
reinforces previous comparisons (Aguayo et al., 2017). 
4.2. Interpretation 
One possibility for the absence of a longitudinal association between 
inflammatory biomarkers and the Fried phenotype may be the general 
rates of healthiness in the LBC1936. As the LBC1936 is a self-selected 
volunteer sample from a relatively affluent area of Scotland, there are, 
on average, higher levels of healthiness when compared to the general 
population (Deary et al., 2007; Taylor et al., 2018). Thus, the greater 
restriction of range in our measures may underestimate the true size of 
effects in the general population. Furthermore, there was significant 
attrition which could have led to a healthy survivor effect whereby 
those who withdrew from the study were more likely to have had 
worsening frailty. This is congruent with findings that early with-
drawers had higher levels of baseline frailty in both the FI and Fried 
phenotype. Previous analyses of the LBC1936 show that compared to 
those who stayed in the study, those who dropped out had significantly 
lower socioeconomic status, fitness levels, grip strength, and cognitive 
ability, all measures which could contribute to a higher level of Fried 
phenotype transition (Taylor et al., 2018). Additionally, although 
women had a marginally higher baseline FI score than men, this did not 
reach statistical significance. This result is incongruent with previous 
research which generally finds that women report higher FI levels than 
men (Gordon et al., 2017), and might reflect further the general heal-
thiness of the LBC1936 (Deary et al., 2007; Taylor et al., 2018). 
Another possible explanation for why CRP and Fibrinogen were 
associated with FI change but not Fried phenotype transitions is the 
substantial difference in their conceptualisation of frailty. Not only do 
the FI and Fried phenotype differ in the composition of their measures 
(biopsychosocial vs purely physical), it may also be that the scale dif-
ferences (categorical vs continuous) add to our discrepant findings. 
Previous research has found similar differences, for example, Gale et al. 
(2018) utilised both the FI and Fried Phenotype to investigate social 
isolation and loneliness, finding different results depending on the 
frailty measure used. Aguayo et al. (2017) argued that different frailty 
scales are often based on different concepts of frailty and that they 
cannot be compared despite aiming to measure a similar outcome. 
Accordingly, it may be that inflammation does contribute to increased 
risk of frailty according to the FI's biopsychosocial definition of frailty 
but not the Fried Phenotype's physical definition. Further research is 
required to replicate these findings and tease out the differences be-
tween different types of frailty measurements and the associations of 
inflammatory biomarkers. 
4.3. Implications for policy/care 
Understanding the association between chronic inflammation and 
frailty progression may be useful for physicians targeting services for 
elderly people. For example, elevated inflammation may not indicate 
the need for immediate clinical care, however it may reinforce the 
benefit of lifestyle changes to potentially attenuate the risk of wor-
sening frailty. The Fried phenotype, whilst unable to capture the subtle 
changes, may be more useful for detecting significant shifts in an in-
dividual's frailty status, indicating the requirement for immediate care 
and intervention. It may also be useful in an older population than the 
LBC1936 where frailty rates are higher and transitions are more sub-
stantial. 
4.4. Strengths and limitations 
A strength of this study is the use of different frailty measurement 
tools. Whilst the optimal way to measure frailty remains a matter of 
dispute it is important to consider that not all tools are consistent in 
their findings, and thus it is important to compare them before reaching 
firm conclusions. Future research may benefit from this method and 
reduce the heterogeneity in the field. This study also has limitations. 
Due to a lack of data at wave 2 we were unable to compute the Fried 
phenotype at all waves. Accordingly, we calculated transitions over a 
12 year period whereby sample attrition took place. Future studies that 
are able to calculate transitions with less attrition may be able to draw 
more generalisable conclusions. Additionally, for our logistic regression 
models we only considered frailty transitions as those who recorded 
worsening frailty over time. We did not distinguish between those who 
either stayed healthy or showed improvement in frailty status over 
time. It may be the case that improvements in frailty are associated with 
reductions in inflammation. Future research may benefit from exploring 
this relationship further. A further limitation concerned our lack of 
inclusion of anti-inflammatory drugs as a covariate, which could have 
acted as a confounder on our results. Use of anti-inflammatory drugs 
typically increase in older age (Fowler et al., 2014) and this potentially 
explains the decreases in Fibrinogen and CRP over time as seen in Figs. 
A1 and A2. 
4.5. Conclusions 
We sought to explore the association between inflammation and 
frailty change over time. As far as we are aware, we are the first study to 
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explore the longitudinal association between inflammation and FI. We 
found differing results depending on the frailty measurement tool used; 
inflammation showed a significant association with frailty over time 
when measured by the FI but not the Fried phenotype. The differences 
in frailty conceptualisation (biopsychosocial vs solely physical) may 
underpin this difference and further research is required to fully un-
derstand these differences. The value of comparing different frailty 
measures has been shown here, and should be continued in future re-
search so that a better understanding of how inflammatory marker 
associations vary between different frailty conceptualisations can be 
established. By doing so, it may be possible to facilitate policy and 
clinical care improvements whereby frailty risk can be identified early, 
via markers like inflammation, and effective interventions can be im-
plemented. 
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Appendix A 
Table A1 
Items constituting the Frailty Index and their coding/cut-off points in the LBC1936.     
Items Coding Cut-offs based on  
Systolic blood pressure Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Diabetes (self-reported) Yes (1) or No (0) Already binary variable 
High Cholesterol (self-reported) Yes (1) or No (0) Already binary variable 
Heart problems (self-reported) Yes (1) or No (0) Already binary variable 
Stroke or mini stroke (self-reported) Yes (1) or No (0) Already binary variable 
Leg pain (self-reported) Yes (1) or No (0) Already binary variable 
Blood circulation issues (self-reported) Yes (1) or No (0) Already binary variable 
Thyroid Disorder (self-reported) Yes (1) or No (0) Already binary variable 
Cancer (self-reported) Yes (1) or No (0) Already binary variable 
Parkinson's disease (self-reported) Yes (1) or No (0) Already binary variable 
Dementia (self-reported) Yes (1) or No (0) Already binary variable 
Arthritis (self-reported) Yes (1) or No (0) Already binary variable 
Any other chronic disease (self-reported) Yes (1) or No (0) Already binary variable 
Polypharmacy (self-reported)  > 4 medications (1), ≤4 medications (0) Previous literature (Theou et al., 2013) 
Body Mass Index (BMI) 18.5 to  < 25 (0), 25 to  < 30 (0.5),  < 18.5 or  >  equal to 
30 (1) 
Previous literature (Chamberlain et al., 2016) 
6 m walk time (gait speed)  > 10 s or physically unable (1),  < 10 s (0) Previous literature (Hoogendijk et al., 2017) 
Able to stand up from a chair Yes (1) or No (0) Already binary variable 
Grip strength (strongest hand and stratified by sex 
and BMI) 
Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Townsend Disability Scale (Townsend, 1979) 11–18 (1), 0–10 (0) Previous literature (Matthews et al., 2016) 
Peak Expiratory Flow rate (stratified by sex) Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Forced expiratory volume (stratified by sex) Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Depression (measured by the HADS) (Zigmond a-
nd Snaith, 1983) 
11–21 (1), 8–10 (0.5), 0–7 (0) Previous literature (Zigmond and Snaith, 1983) 
Anxiety (measured by the HADS) (Zigmond and 
Snaith, 1983) 
11–21 (1), 8–10 (0.5), 0–7 (0) Previous literature (Zigmond and Snaith, 1983) 
Mini-Mental State Examination (MMSE) (Folstein 
et al., 1975)  
< 10 (1), 11–17 (0.75), 18–20 (0.5), 20–24 (0.25),  > 24 (0) Previous literature (Searle et al., 2008) 
Digit Symbol(Wechsler, 2003) Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
(continued on next page) 
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Table A1 (continued)    
Items Coding Cut-offs based on  
Block Design(Wechsler, 2003) Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Verbal Fluency(Wechsler, 2003) Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Matrix Reasoning(Wechsler, 2003) Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Reaction time test(Cox et al., 1993) Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Delayed recall(Wechsler, 2003) Bottom 5th percentile (1), 5th–20th percentile (0.5), Above 
20th percentile (0) 
Recommended technique where no established cut-offs available 
(Theou et al., 2015) 
Note. HADS: Hospital Anxiety and Depression scale.  
Deriving the fried criteria 
The Fried Criteria was comprised on five dimensions. These were measured in the LBC1936 as follows; 
Weight loss 
Weight was measured using an electronic weighing scale, and height was measured in metres using a stadiometer. From this, it was possible to 
compute BMI by dividing weight by height squared. At baseline, weight loss was defined as a BMI less than 18.5 kg/m2. At waves 3 and 4, weight loss 
was defined as a loss of weight of 10% or more since their previous visit or a BMI less than 18.5 kg/m2. 
Exhaustion 
Exhaustion was measured using the Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983). Exhaustion was scored as 
present if the participant responded ‘very often’ or ‘nearly all the time’ to the item ‘I feel as if I'm slowed down’. 
Physical activity 
A question asking participants about their usual level of physical activity was used with six responses ranging from moving only when necessary, 
to heavy exercise or sport several times a week. In line with previous publications (Gale et al., 2017), participants in the lowest sex-specific 20% of 
the distribution were defined as having low physical activity. 
Walking speed 
Participants were recorded walking a distance of six metres at maximum speed. After adjusting for sex and height, those in the lowest 20% of the 
distribution were considered to have a slow walking speed. 
Weakness 
Maximum grip strength was measured in all participants using a dynamometer. Participants were measured three times with the strongest 
attempt being used for analysis. After adjusting for sex and BMI, those in the lowest 20% of the distribution were defined as having weakness. 
Appendix B. Defining occupational social class 
Occupational social class was based upon principal occupation, coded in line with the 1980 census (General, 1991). Five social class categories 
were used: professional, managerial, skilled non-manual, skilled manual, and semiskilled/unskilled. The women in the cohort were asked for their 
husband's occupation as well as their own, and they were assigned a social class based on the highest occupation of the household. This was derived 
from their own occupation for about half of the women, and from their husband's occupation for the remainder. 
Childhood IQ was derived from Moray House Test scores at age 11 (Penrose, 1949) as part of the LBC1936. Raw scores were corrected for age in 
days at time of testing and converted to an IQ scale where mean (SD) = 100 (15). 
Table A2 
Baseline differences in characteristics for each category of the Fried phenotype in the LBC1936.       
Variables Non-frail (n = 478) Pre-frail (n = 520) Frail (n = 93) p-Value  
CRP mg/L: mean (SD) 3.2 (2.3) 3.7 (2.6) 4.1 (2.6)   < 0.001⁎⁎⁎ 
Fibrinogen g/L: mean (SD) 3.2 (0.6) 3.3 (0.7) 3.6 (0.8)   < 0.001⁎⁎⁎ 
Sex, n (%) 
Male 
Female  
245 (51%) 
233 (49%)  
259 (50%) 
261 (50%)  
44 (47%) 
49 (53%)  
0.8 
Body mass index (BMI), mean (SD) 27.1 (3.7) 28.2 (4.5) 29.4 (5.8)   < 0.001⁎⁎⁎ 
Smoking status, n (%) 
Current 
Ex 
Never  
39 (8%) 
203 (43%) 
236 (49%)  
66 (13%) 
223 (43%) 
231 (44%)  
20 (21%) 
39 (42%) 
34 (37%)   
< 0.01⁎⁎ 
Alcohol (units per week), mean (SD) 11.4 (14.8) 10.2 (13.8) 7.94 (12.6)  0.1 
Social class, n (%) 
Professional  104 (22%)  78 (15%)  8 (9%)   
< 0.001⁎⁎⁎ 
(continued on next page) 
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Table A2 (continued)      
Variables Non-frail (n = 478) Pre-frail (n = 520) Frail (n = 93) p-Value  
Managerial 
Skilled non-manual 
Skilled manual 
Semiskilled/Unskilled 
188 (40%) 
104 (22%) 
56 (12%) 
18 (4%) 
185 (36%) 
122 (24%) 
108 (21%) 
19 (4%) 
29 (33%) 
20 (23%) 
24 (27%) 
7 (8%) 
Childhood IQ, mean (SD) 102.1 (14.4) 98.9 (14.8) 95.2 (17.4)   < 0.001⁎⁎⁎ 
Years of Education, mean (SD) 10.9 (1.2) 10.7 (1.1) 10.3 (0.9)   < 0.001⁎⁎⁎ 
History of diabetes, n (%) 
Yes 
No  
18 (4%) 
460 (96%)  
48 (9%) 
472 (91%)  
25 (27%) 
68 (73%)   
< 0.001⁎⁎⁎ 
History of cardiovascular disease, n (%) 
Yes 
No  
92 (19%) 
386 (81%)  
134 (26%) 
386 (74%)  
42 (45%) 
51 (55%)   
< 0.001⁎⁎⁎ 
History of high cholesterol, n (%) 
Yes 
No  
147 (31%) 
330 (69%)  
192 (37%) 
328 (63%)  
47 (51%) 
46 (49%)   
< 0.01⁎⁎ 
History of stroke, n (%) 
Yes 
No  
15 (3%) 
463 (97%)  
30 (6%) 
490 (94%)  
9 (10%) 
84 (90%)   
< 0.05⁎ 
History of thyroid disease, n (%) 
Yes 
No  
35 (7%) 
443 (93%)  
53 (10%) 
467 (90%)  
11 (12%) 
81 (88%)  
0.2 
History of cancer, n (%) 
Yes 
No  
61 (13%) 
417 (87%)  
58 (11%) 
462 (89%)  
15 (16%) 
78 (84%)  
0.4 
History of Parkinson's disease, n (%) 
Yes 
No  
2 (> 1%) 
476 (< 99%)  
1 (> 1%) 
519 (< 99%)  
2 (> 1%) 
91 (< 99%)   
< 0.05⁎ 
History of arthritis, n (%) 
Yes 
No  
175 (37%) 
302 (63%)  
241 (46%) 
279 (54%)  
61 (66%) 
32 (34%)   
< 0.001⁎⁎⁎ 
Depressive symptoms, mean (SD) 1.24 (1.48) 1.69 (1.87) 3.53 (2.61)   < 0.001⁎⁎⁎ 
⁎⁎⁎ P  <  .001. 
⁎⁎ P  <  .01. 
⁎ P  <  .05. 
Fig. A1. A plot of CRP levels the course of follow-up. 
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Fig. A2. A plot of Fibrinogen levels over the course of follow-up.  
Appendix C. Supplementary data 
Supplementary data to this article can be found online at https://doi.org/10.1016/j.exger.2020.111055.  
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